Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Jilma

Showing results (11-20 of 468) with videos related to

Pageof 47
Sort By:
The New England Journal of Medicine|April 27, 2017
Ocrelizumab in Primary Progressive and Relapsing Multiple SclerosisChristian Schoergenhofer, Bernd Jilma
Critical Care Medicine|March 20, 2012
Disseminated intravascular coagulation in heat stroke: a hot topicBernd Jilma, Ulla Derhaschnig
Thrombosis and Haemostasis|April 30, 2004
Mechanism of action of drotrecogin alfa activated (rhAPC)Bernd Jilma, Ulla Derhaschnig
Human Vaccines & Immunotherapeutics|January 27, 2015
Product review on the JE vaccine IXIAROChrista Firbas, Bernd Jilma
Drug Discovery Today|April 3, 2025
Are leukotrienes really the world's best bronchoconstrictors and at least 100 to 1000 times more potent than histamine?Thomas Boehm, Bernd Jilma
Thrombosis and Haemostasis|December 8, 2009
Assessment of platelets and the endothelium in patients presenting with acute coronary syndromes--is there a future?Ulla Derhaschnig, Bernd Jilma
Thrombosis and Haemostasis|December 5, 2017
Tecarfarin: A Novel Vitamin K AntagonistEva-Luise Hobl, Bernd Jilma
Cardiovascular Research|July 19, 2002
Female gender, menstrual cycle and estradiol affect plasma levels of monocyte chemotactic protein-1 (MCP-1) in humansBernd Jilma, Petra Jilma-Stohlawetz
Blood Advances|March 12, 2024
Add-on erythropoietin in autoimmune hemolytic anemiaMiriam M Moser, Bernd Jilma
Thrombosis and Haemostasis|May 1, 2015
Towards the development of specific antidotes: Idarucizumab for reversal of dabigatran effectsEva-Luise Hobl, Bernd Jilma
Pageof 47

Showing results (11-20 of 468) with videos related to

Sort By:
Pageof 47
The New England Journal of Medicine|April 27, 2017
Ocrelizumab in Primary Progressive and Relapsing Multiple SclerosisChristian Schoergenhofer, Bernd Jilma
Critical Care Medicine|March 20, 2012
Disseminated intravascular coagulation in heat stroke: a hot topicBernd Jilma, Ulla Derhaschnig
Thrombosis and Haemostasis|April 30, 2004
Mechanism of action of drotrecogin alfa activated (rhAPC)Bernd Jilma, Ulla Derhaschnig
Human Vaccines & Immunotherapeutics|January 27, 2015
Product review on the JE vaccine IXIAROChrista Firbas, Bernd Jilma
Drug Discovery Today|April 3, 2025
Are leukotrienes really the world's best bronchoconstrictors and at least 100 to 1000 times more potent than histamine?Thomas Boehm, Bernd Jilma
Thrombosis and Haemostasis|December 8, 2009
Assessment of platelets and the endothelium in patients presenting with acute coronary syndromes--is there a future?Ulla Derhaschnig, Bernd Jilma
Thrombosis and Haemostasis|December 5, 2017
Tecarfarin: A Novel Vitamin K AntagonistEva-Luise Hobl, Bernd Jilma
Cardiovascular Research|July 19, 2002
Female gender, menstrual cycle and estradiol affect plasma levels of monocyte chemotactic protein-1 (MCP-1) in humansBernd Jilma, Petra Jilma-Stohlawetz
Blood Advances|March 12, 2024
Add-on erythropoietin in autoimmune hemolytic anemiaMiriam M Moser, Bernd Jilma
Thrombosis and Haemostasis|May 1, 2015
Towards the development of specific antidotes: Idarucizumab for reversal of dabigatran effectsEva-Luise Hobl, Bernd Jilma
Pageof 47